All news

© Choreograph / Getty Images

Corium sells off CDMO business for $400m

By Ben Hargreaves

The company will split into two separate entities, one will focus on the development of neuroscience therapies and the other will become a standalone CDMO.

Pic:getty/sdecoret

CPhI Frankfurt: 5 ways to make the most of the event

By staff reporter

CPhI Frankfurt takes place next week: covering the full supply chain from research and manufacturing to packaging and finished products. Here’s five ideas on how to make the most of the event.

© george tsartsianidis / Getty Images

CPHI Pharma Award finalists announced

The awards cover innovations spanning the full pharmaceutical supply chain and feature many of pharma’s biggest names and breakthrough companies.

© imaginima / Getty Images

Thermo Fisher launches decentralized clinical trial network

By Ben Hargreaves

The company, through its subsidiary, PPD, announced that it had created a network that would provide learning materials to those investigators and research sites looking to use decentralized clinical trials (DCTs) for drug development.

© royyimzy / Getty Images

People on the Move: October 2022

By Stephen Daniells

This month’s announcements of new hires and appointments include Parexel, Boyds, ACG, and other key companies.

© Jomkwan / Getty Images

GSK picks up antibiotic in $66m deal

By Ben Hargreaves

GSK pays for the exclusive license of Spero‘s late-stage antibiotic to potentially treat complicated urinary tract infections.

Follow us

Products

View more

Webinars